Article
Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members.
Breast cancer research and treatment - 1 Apr 2012
Thomassen Mads, Blanco Ana, Montagna Marco, Hansen Thomas V O, Pedersen Inge S, Gutiérrez-Enríquez Sara, Menéndez Mireia, Fachal Laura, Santamariña Marta, Steffensen Ane Y, Jønson Lars, Agata Simona, Whiley Phillip, Tognazzo Silvia, Tornero Eva, Jensen Uffe B, Balmaña Judith, Kruse Torben A, Goldgar David E, Lázaro Conxi, Diez Orland, Spurdle Amanda B, Vega Ana
Abstract excerpt
Mutations in BRCA1 and BRCA2 predispose carriers to early onset breast and ovarian cancer. A common problem in clinical genetic testing is interpretation of variants with unknown clinical significance. The Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) consortium was initiated to evaluate and implement strategies to characterize the clinical significance of BRCA1 and BRCA2...
Topics
- Adult
- Aged
- BRCA1 Protein
- BRCA2 Protein
- Base Sequence
- Computer Simulation
- Female
- Genetic Association Studies
- Genetic Predisposition to Disease
